Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...

An international study has identified 11 new gene alterations connected to more aggressive prostate cancer using a simple blood test. The discovery could improve treatments for prostate cancer by ...

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

French pharma company Servier and biopharma company Oncodesign have reach the first milestone in their collaboration on research and development into new drug candidates for Parkinson’s disease. In a ...

The European Commission (EC) has approved Roche’s highly anticipated haemophilia treatment Hemlibra (emicizumab). The rare bleeding disorder treatment, which is cleared in the EU for routine ...

Merck KGaA and Pfizer have staked a claim to the first-line renal cell carcinoma market, with data on a new combination that analyst say could challenge to become a new standard for the disease. The ...

The European Union is demanding that AstraZeneca (AZ) delivers 120 million doses of its COVID-19 vaccine by the end of June, threatening financial sanctions if the company fails to meet this target.

The American Medical Association (AMA) has urged the US Food and Drug Administration (FDA) to work with the medical community to provide transparency around COVID-19 vaccines currently in development.

The importance of Merck KGaA’s immuno-oncology deal with Pfizer was evident as the company reported weak pharma sales this morning. Favourable exchange rates flattered the Merck Serono healthcare unit ...

An artificial intelligence programme has proved to be more effective than two radiologists working together at diagnosing breast cancer from mammogram images, says a new study. The AI technology was ...

Gilead has posted its results for the first quarter of 2021, noting an increase in revenues for the quarter, driven by its COVID-19 pill Veklury, while sales of its HIV drugs took a hit. The total ...